Vitek AST Kit
Regulatory & QualityBioMérieux Vitek AST Kit Recall Given FDA Class I TreatmentBioMérieux Vitek AST Kit Recall Given FDA Class I Treatment
The recall details that the affected kits contain incorrect concentrations of Ceftriaxone antibiotic in two wells.
Sign up for the QMED & MD+DI Daily newsletter.